New insight into mode of action of Colostrinin™

Journal of Nutrition, Health and Aging

Volumn 14, Issue 4, 2010, Pages 336-

  Stewart, Michael G ^a  

^a OPEN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; COLOSTRININ; NOOTROPIC AGENT; UNCLASSIFIED DRUG; ANTIOXIDANT; COLOSTRININE; FAS LIGAND; PEPTIDE; PROLINE;

APOPTOSIS; CELL PROTECTION; CYTOTOXICITY; DRUG MECHANISM; HUMAN; LETTER; NEUROBLASTOMA CELL; NEUROPROTECTION; PRIORITY JOURNAL; ALZHEIMER DISEASE; DIET SUPPLEMENTATION; DRUG EFFECTS; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIOXIDANTS; APOPTOSIS; DIETARY SUPPLEMENTS; FAS LIGAND PROTEIN; HUMANS; PEPTIDES; PROLINE;

EID: 77951809902     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12603-010-0076-z     Document Type: Letter

References (4)

1. Douraghi-Zadeh D., Matharu B., Razvi A., Austen B. The protective effects of the nutraceutical, Colostrinin, against Alzheimer's disease, is mediated via prevention of apoptosis in human neurones induced by aggregated -amyloid". J Nutr Health Aging. 2009; 13(6):522-527.
2. Stewart MG (2008) Colostrinin: a naturally occurring compound derived from mammalian colostrum with efficacy in treatment of neurodegenerative diseases, including Alzheimer's. Expert Opin Pharmacother. 2008 9(14):2553-2559
3. Boldogh I, Kruzel ML. (2008) Colostrinin: an oxidative stress modulator for prevention and treatment of age-related disorders. J Alzheimers Dis. 13(3):303-321
4. Szaniszlo P, German P, Hajas G, Saenz DN, Woodberry MW, Kruzel ML, Boldogh I. (2009) Effects of colostrinin on gene expression-transcriptomal network analysis. Int Immunopharmacol. 9(2): 181-193